Capricor Therapeutics
CAPR
trading on NASDAQ
since 2002
$7.64
(Δ -4.19%)
-$0.32 since open
Capricor Therapeutics specializes in developing innovative therapies for rare diseases and neurodegenerative conditions through cutting-edge cell-based and gene therapy methods.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $7.00 | $8.68 | $6.74 | $452.51M | 19.66M |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| -$0.53 | n/a | +Inf | -Inf% | -Inf% | 0% |